Projects per year
Personal profile
Research expertise
Extensive experience in laboratory strengthening in resource-limited settings and clinical trials.
Research focus on the mechanisms and diagnosis of drug resistance in Mycobacterium tuberculosis.
Education/Academic qualification
Biomedical Sciences, Doctor of Philosophy, Identifying and addressing the gaps impeding fast and accurate phenotypic drug-susceptibility testing of Mycobacterium tuberculosis , University of Antwerp
Award Date: 3-Sept-2024
Biomedical Sciences, Master of Science in Medical Microbiology, Molecular epidemiology of Leptospirosis in central Sri Lanka, University of Peradeniya
Award Date: 6-Oct-2010
Biological Sciences, Bachelor of Science, University of Kelaniya
Award Date: 1-May-2008
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Finished
-
Knowledge gaps impeding Mycobacterium tuberculosis's fast and accurate phenotypic drug-susceptibility testing
Rupasinghe, R. A. P., de Jong, B., Rigouts, L. & Rigouts, L.
12/12/23 → 3/09/24
Project: PhD-project
-
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid
Rupasinghe, P., Reenaers, R., Vereecken, J., Rigouts, L., Mulders, W., Niemann, S., Merker, M., Koeser, C. U., Cogneau, S., Omar, S. V., Decroo, T. & de Jong, B., 2024, In: Microbiology Spectrum. 9 p., Spectrum.00070-24.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Reduced critical concentration might not have improved MGIT-based DST’s sensitivity to rifampicin
Rupasinghe, P., de Rijk, W. B., Calderon, R., Rigouts, L., Guglielmetti, L., Mitnick, C. D., de Jong, B., Rusheed, N., Ardizzoni, E., Ha, D. T., Hang, P. T., Bulane, A., Chingisova, L., Hirani, N., Asif, S., Azka, A., Barreda, N., Parveen, S. & Zubair, M., 2024, In: Antimicrobial Agents and Chemotherapy. 68, 5, e01701-23.Research output: Contribution to journal › Letter › peer-review
-
Re-evaluation of critical concentrations of antituberculosis fluoroquinolones in the mycobacteria growth indicator tube 960 System
Rupasinghe, R. A. P., Vereecken, J., de Jong, B., Rigouts, L. & Driesen, M., 2023, In: International Journal of Mycobacteriology. 12, 3, p. 316-323 7 p., 144_23.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile17 Downloads (Pure) -
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial
Rupasinghe, P., Patil, S. B., Tamirat, M., Khazhidinov, K., Ardizzoni, E., Atger, M., Austin, A., Baudin, E., Bekhit, M., Bektasov, S., Berikova, E., Bonnet, M., Caboclo, R., Chaudhry, M., Chavan, V., Cloez, S., Coit, J. M., Coutisson, S., Dakenova, Z., de Jong, B., & 33 others , 2023, In: Trials. 24, 1, 14 p., 773.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Balancing access to BPaLM regimens and risk of resistance
Van Rie, A., Walker, T. M., de Jong, B., Rupasinghe, P., Riviere, E., Gagneux, S., Supply, P., Dreyer, V., Niemann, S., Goig, G. A. & Cirillo, D. M., 2022, In: Lancet Infectious Diseases. 22, 10, p. 1411-1412 2 p.Research output: Contribution to journal › Comment/debate › peer-review